Central Drugs Standard Control Organization

Jump to

New e-platform to help India weed out substandard drugs

Unlike the US and Europe, India does not currently have a tracking system for the drug supply chain.
Govt looks to overhaul Drugs and Cosmetics Act

The central drug standards authority has issued a notice to revisit the Drugs and Cosmetics Act and Rules, reports Ashmit Kumar.
New guidelines to cut approval time of biosimilars in half

Priya Sheth of CNBC-TV18 reports that the regulator plans to categorically outline aspect of post-marketing safety of drugs. These new regulations may cut approval timeline by more than half for biosimilars.
More trouble for Ranbaxy as central regulator finds deficiencies

Joint inspections with eight other regulators carried at six of Ranbaxy‘s laboratories in Himachal Pradesh found discrepancies in testing, stability standards and expiry dates, among other standards.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Central Drugs Standard Control Organization

New e-platform to help India weed out substandard drugs

Govt looks to overhaul Drugs and Cosmetics Act

New guidelines to cut approval time of biosimilars in half

More trouble for Ranbaxy as central regulator finds deficiencies